CSL Ltd (CSL)

313.81
+9.23(+3.03%)
  • Volume:
    1,165,236
  • Bid/Ask:
    313.80/313.81
  • Day's Range:
    307.03 - 314.28
Trading near 52-week High

CSL has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

1 / 2

CSL Overview

Prev. Close
304.58
Day's Range
307.03-314.28
Revenue
11.64B
Open
307.89
52 wk Range
240.1-314.28
EPS
4.81
Volume
1,165,236
Market Cap
151.23B
Dividend (Yield)
3.1812
(1.08%)
Average Volume (3m)
660,263
P/E Ratio
45.98
Beta
0.184
1-Year Change
21.26%
Shares Outstanding
482,217,446
Next Earnings Date
13 Feb 2023
What is your sentiment on CSL?
or
Market is currently closed. Voting is open during market hours.

CSL Ltd News

CSL Ltd Analysis

CSL Ltd Company Profile

CSL Ltd Company Profile

Employees
30000
Market
Australia

CSL Limited (CSL) is a biotechnology company engaged in developing and delivering biotherapies and influenza vaccines that treat people with serious diseases and chronic medical conditions. CSL provides a portfolio of life saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Its segments include CSL Behring and Seqirus. CSL Behring manufactures, markets, and develops plasma therapies (plasma products and recombinants), conducts early-stage research on plasma and non-plasma therapies, excluding influenza, receives license and royalty income from the commercialization of intellectual property and undertakes the administrative and corporate function required to support the Company. Seqirus manufactures and distributes non-plasma biotherapeutic products and develops influenza related products. CSL’s products include HIZENTRA, PRIVIGEN, IDELVION, HAEMATE, KCENTRA, HAEGARDA, ZEMAIRA/RESPREEZA, FLUAD and FLUCELVAX.

Read More

Analyst Price Target

Average228.09 (-27.31% Downside)
High328.2104
Low176.4926
Price313.81
No. of Analysts15
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyStrong BuyBuyStrong Buy
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
  • Is this inverse ?
    0
    • do I buy
      0
      • on the dip
        0
      • buy the dip joan. about to pop
        0
    • It can only fall so much
      0
      • Anyone knows why CSL keep dropping??
        3
        • Not as strong forecasts for future earnings
          0
        • Most business in US so profits less as US dollar taking a hit, alot of the work they do has stopped since covid.
          2
        • It has rallied hard over many years. I think it is in a consolidation stage and just coming back to fair value.
          1
      • As of 27/0220 CSL is going up after a temporary fall. Rather its an opputunity to stock up and avoid regrets. Plus exdividend next month. Have fun fellow traders and investers.
        9
        • It will go up to at least 220 ; T2: 232
          0
          • looks like it's on a downtrend when checking yearly monthly charts, I'd be looking for some pretty solid bullish reversal indicators before considering
            3
            • invest later when they are at their lowest
              0
              • is this good to invest in ?
                1
                • Do some research and you might find out.
                  1